Cargando…

Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study

Detalles Bibliográficos
Autores principales: Kaplan, Gilaad G, Ma, Christopher, Charlton, Carmen, Kanji, Jamil N, Tipples, Graham, Sharifi, Nastaran, Herauf, Michelle, Coward, Stephanie, Ingram, Richard J M, Hracs, Lindsay, Benchimol, Eric I, Panaccione, Remo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120372/
https://www.ncbi.nlm.nih.gov/pubmed/34340997
http://dx.doi.org/10.1136/gutjnl-2021-325238
_version_ 1784710910007312384
author Kaplan, Gilaad G
Ma, Christopher
Charlton, Carmen
Kanji, Jamil N
Tipples, Graham
Sharifi, Nastaran
Herauf, Michelle
Coward, Stephanie
Ingram, Richard J M
Hracs, Lindsay
Benchimol, Eric I
Panaccione, Remo
author_facet Kaplan, Gilaad G
Ma, Christopher
Charlton, Carmen
Kanji, Jamil N
Tipples, Graham
Sharifi, Nastaran
Herauf, Michelle
Coward, Stephanie
Ingram, Richard J M
Hracs, Lindsay
Benchimol, Eric I
Panaccione, Remo
author_sort Kaplan, Gilaad G
collection PubMed
description
format Online
Article
Text
id pubmed-9120372
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-91203722022-06-04 Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study Kaplan, Gilaad G Ma, Christopher Charlton, Carmen Kanji, Jamil N Tipples, Graham Sharifi, Nastaran Herauf, Michelle Coward, Stephanie Ingram, Richard J M Hracs, Lindsay Benchimol, Eric I Panaccione, Remo Gut PostScript BMJ Publishing Group 2022-06 2021-08-02 /pmc/articles/PMC9120372/ /pubmed/34340997 http://dx.doi.org/10.1136/gutjnl-2021-325238 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle PostScript
Kaplan, Gilaad G
Ma, Christopher
Charlton, Carmen
Kanji, Jamil N
Tipples, Graham
Sharifi, Nastaran
Herauf, Michelle
Coward, Stephanie
Ingram, Richard J M
Hracs, Lindsay
Benchimol, Eric I
Panaccione, Remo
Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
title Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
title_full Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
title_fullStr Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
title_full_unstemmed Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
title_short Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
title_sort antibody response to sars-cov-2 among individuals with ibd diminishes over time: a serosurveillance cohort study
topic PostScript
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120372/
https://www.ncbi.nlm.nih.gov/pubmed/34340997
http://dx.doi.org/10.1136/gutjnl-2021-325238
work_keys_str_mv AT kaplangilaadg antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT machristopher antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT charltoncarmen antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT kanjijamiln antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT tipplesgraham antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT sharifinastaran antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT heraufmichelle antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT cowardstephanie antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT ingramrichardjm antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT hracslindsay antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT benchimolerici antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy
AT panaccioneremo antibodyresponsetosarscov2amongindividualswithibddiminishesovertimeaserosurveillancecohortstudy